JWK002 gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JWK002 gene therapy, covering 2025-02-07 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS) [EARLY_Phase 1]